Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats

Pain

Volumn 102, Issue 1-2, 2003, Pages 9-16

  Tortorici, Víctor ^a,b   Nogueira, Lourdes ^a   Salas, Rafael ^a   Vanegas, Horacio ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Ctro de Biofis/Bioquim   (United States)

Author keywords

Cholecystokinin; Microinjection; Morphine; Periaqueductal gray; Proglumide; Tolerance

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; MORPHINE; PROGLUMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CANNULATION; CONTROLLED STUDY; DEVICE; DRUG EFFECT; DRUG TOLERABILITY; FOLLOW UP; MALE; MICROINJECTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

EID: 0037333777     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0304-3959(02)00153-7     Document Type: Article

References (33)

1. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain. 64:1996;535-543.
2. Boden P., Woodruff G.N. Ionic mechanisms underlying cholecystokinin action in rat brain. Ann NY Acad Sci. 713:1994;129-137.
3. + conductance. J Neurophysiol. 74:1995;990-1000.
4. Cheng Z.-F., Fields H.L., Heinricher M.M. Morphine microinjected into the periaqueductal gray has differential effects on 3 classes of medullary neurons. Brain Res. 375:1986;57-65.
5. Dourish C.T., O'Neill M.F., Coughlan J., Kitchener S.J., Hawley D., Iversen S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur J Pharmacol. 176:1990;35-44.
6. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
7. Fields H.L., Basbaum A.I. Central nervous system mechanisms of pain modulation. Wall P.D., Melzack R. Textbook of pain. 4th ed. 1999;309-329 Churchill Livingstone, London.
8. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci. 14:1991;219-245.
9. Fields H.L., Malick A., Burstein R. Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J Neurophysiol. 74:1995;1742-1759.
10. Heinricher M.M., McGaraughty S., Tortorici V. Circuitry underlying anti-opioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol. 85:2001;280-286.
11. Hoffmann O., Wiesenfeld-Hallin Z. The CCK-B receptor antagonist CI 988 reverses tolerance to morphine in rats. NeuroReport. 5:1994;2565-2568.
12. Jacquet Y.F., Lajtha A. The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections. Brain Res. 103:1976;501-513.
13. Kubota Y., Inagaki S., Shiosaka S., Cho H.J., Tateishi K., Hashimura E., Hamaoka T., Tohyama M. The distribution of cholecystokinin octapetide-like structures in the lower brain stem of the rat: an immunohistochemical analysis. Neuroscience. 9:1983;587-604.
14. Li Y., Han J.-S. Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat. Brain Res. 480:1989;105-110.
15. Liu H., Chandler S., Beitz A.J., Shipley M.T., Behbehani M.M. Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies. Brain Res. 642:1994;83-94.
16. + conductance in hippocampal interneurons. J Neurosci. 17:1997;4994-5003.
17. Moreau J.-L.S, Fields H.L. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res. 397:1986;37-46.
18. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press, San Diego, CA.
19. Siuciak J.A., Advokat C. Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine. Brain Res. 424:1987;311-319.
20. Stanfa L.C., Dickenson A.H. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation. Br J Pharmacol. 108:1993;967-973.
21. Tortorici V., Morgan M.M., Vanegas H. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla. Pain. 89:2000;237-244.
22. Tortorici V., Robbins C.S., Morgan M.M. Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat. Behav Neurosci. 113:1999;833-839.
23. Valverde O., Maldonado R., Fournie-Zaluski M.C., Roques B.P. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. J Pharmacol Exp Ther. 270:1994;77-88.
24. Vanegas H., Barbaro N.M., Fields H.L. Tail-flick related activity in medullospinal neurons. Brain Res. 321:1984;135-141.
25. Vanegas H, Salas R, Nogueira L, Tortorici V. PAG microinjection of the CCK antagonist proglumide prevents and reverts tolerance to systemic or PAG-microinjected morphine in rats. Soc Neurosci Abstr 2001;27:Prog No. 6167.
26. Vaughan C.W., Ingram S.L., Connor M.A., Christie M.J. How opioids inhibit GABA-mediated neurotransmission. Nature (Lond). 390:1997;611-614.
27. Watkins L.R., Kinscheck I.B., Kaufman E.F.S., Miller J., Frenk H., Mayer D.J. Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. Brain Res. 327:1985;181-190.
28. Watkins L.R., Kinscheck I.B., Mayer D.J. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science. 224:1984;395-396.
29. Watkins L.R., Kinscheck I.B., Mayer D.J. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. Brain Res. 327:1985;169-180.
30. Wiesenfeld-Hallin Z., Alster P., Grass S., Hoffmann O., de Araujo Lucas G., Plesan A., Xu X.-J. Opioid sensitivity in antinociception: role of anti-opioid systems with emphasis on cholecystokinin and NMDA receptors. Prog Pain Res Manage. 14:1999;237-252.
31. B receptors, prevents morphine tolerance in the rat. Br J Pharmacol. 105:1992;591-596.
32. Zhou Y., Sun Y.-H., Zhang Z.-W., Han J.-S. Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine. NeuroReport. 3:1992;1121-1123.
33. B receptor antagonist L-365, 260 in rat spinal cord. Eur J Pharmacol. 234:1993;147-154.